XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 125,650 $ 145,647
Marketable securities 400,650 400,576
Prepaid expenses and other current assets 7,865 8,463
Total current assets 534,165 554,686
Restricted cash 286 284
Marketable securities, non-current 0 16,506
Other investments 19,000 32,001
Property and equipment, net 97,836 102,654
Operating lease right-of-use assets 38,695 39,663
Other non-current assets 4,238 4,235
Total assets 694,220 750,029
Current liabilities:    
Accounts payable 4,895 4,817
Accrued liabilities and other current liabilities 24,914 28,126
Success payment liabilities 2,544 1,576
Total current liabilities 32,353 34,519
Operating lease liabilities, non-current 55,159 56,894
Other non-current liabilities 3,551 3,664
Total liabilities 91,063 95,077
Commitments and contingencies (Note 11)
Stockholders’ equity:    
Preferred stock, $0.0001 par value; 10,000 shares authorized at March 31, 2024 and December 31, 2023; no shares issued and outstanding at March 31, 2024 and December 31, 2023 0 0
Common stock, $0.0001 par value; 500,000 shares authorized at March 31, 2024 and December 31, 2023; 254,927 and 253,958 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively 25 25
Additional paid-in capital 1,666,315 1,657,133
Accumulated other comprehensive loss (404) (94)
Accumulated deficit (1,062,779) (1,002,112)
Total stockholders’ equity 603,157 654,952
Total liabilities and stockholders’ equity $ 694,220 $ 750,029